Search

Your search keyword '"LaBarbera, Daniel V."' showing total 191 results

Search Constraints

Start Over You searched for: Author "LaBarbera, Daniel V." Remove constraint Author: "LaBarbera, Daniel V."
191 results on '"LaBarbera, Daniel V."'

Search Results

7. Data from Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

8. Data from First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

9. Supplementary Data from First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

10. Supplementary Data from Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

11. Figure S1 from Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

13. High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog): Central Role for PTEN in 5-Azacytidine Protection Against Pathological Vascular Remodeling

14. Supplementary Tables 1-7 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

15. Supplementary Figure 6 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

16. Supplementary Figure 1 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

17. Supplementary Figure 2 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

18. Supplementary Figure 7 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

19. Supplementary Figure 5 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

20. Supplementary Figure 3 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

21. Supplementary Figure 4 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

27. Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L

30. Supplemental Material, Supplemental_Material_for_Advanced_High-Throughput_Imaging_Applications_of_Clonogenicity_in_Cancer_by_Esquer_et_al. - Advanced High-Content-Screening Applications of Clonogenicity in Cancer

31. Solution kinetics of CC-1065 A-ring opening: Substituent effects and general acid/base catalysis

32. First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

33. Drug Design Targeting T-Cell Factor-Driven Epithelial–Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer

35. Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

36. Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

39. The total synthesis of neoamphimedine

41. SBI2 HCS/HCA 3D Imaging: Best Practices and Unmet Needs Colloquium

44. Novel Microtubule-Targeting 7-Deazahypoxanthines Derived from Marine Alkaloid Rigidins with Potent in Vitro and in Vivo Anticancer Activities

47. SBI2 HCS/HCA 3D Imaging: Best Practices and Unmet Needs Colloquium.

Catalog

Books, media, physical & digital resources